中国全科医学

• •

特发性膜性肾病中西医结合诊疗指南(2025)

中华中医药学会肾病分会,广东省中医药学会肾病专业委员会   

  • 通讯作者: 包崑,主任医师/教授
    执笔人:苏佩玲,杨丽虹,包崑
  • 基金资助:
    国 家 自 然 科 学 基 金 资 助 项 目(82574958); 广 州 市 科 技 局 计 划 项 目(2024A03J0117,2024A03J0714,2025A03J3150,2025A03J4062);省部共建中医湿证国家重点实验室专项(SZ2021ZZ09,SZ2021ZZ36,SZ2024KF11);广东省中医院中医药科学技术研究专项资助项目(YN2023HL03,YN2023MB10,YN2024MS033,YN2024MS019,YN2024G2RPY022)

Diagnosis and Treatment Guideline of Integrated Traditional Chinese and Western Medicine for Idiopathic Membranous Nephropathy (2025)

Nephrology Branch of China Association of Chinese Medicine, Nephrology Committee of Guangdong Provincial Association of Chinese Medicine   

摘要: 特发性膜性肾病占我国肾小球疾病的 24.9%,已跃居第 2 位且比例有逐年增高趋势。中医药联合现代医学治疗已广泛应用于特发性膜性肾病的临床实践中,然而目前国内外尚缺乏特发性膜性肾病中西医结合诊疗的实践指南。本指南按照国际指南制订方法与步骤,证据质量及推荐意见强度使用 GRADE 方法,通过专家访谈,确定指南范围、形成临床问题提纲;基于访谈结果和现有中西医肾病指南、权威教材以及临床研究文献的系统梳理拟定临床问题、特发性膜性肾病疗效评价指标以及中医证型的调查清单,在全国范围内进行专家调查;针对纳入指南的临床问题系统检索证据并进行质量评价;通过专家共识会议,最终形成关于中西医结合诊疗特发性膜性肾病的 8 条推荐意见。本指南聚焦于中西医结合诊疗特发性膜性肾病的临床实践,可供执业中医师(中西医结合)、执业医师、政策制定者等人员使用。

关键词: 肾小球肾炎, 膜性;特发性膜性肾病;中西医结合;中医药疗法;循证实践;诊疗指南

Abstract: In China, idiopathic membranous nephropathy (IMN) accounts for 24.9% of glomerular diseases, the second highest share, and is increasing year by year. Combined therapy of Chinese and Western medicine has been widely used in the clinical practice of IMN. However, there are no evidence-based practice guidelines for the treatment of IMN with integrated traditional Chinese and Western medicine.his guideline followed the methods and steps of the guideline development manual. The level of the body of the evidence was assessed by the GRADE. An outline of the clinical questions was formulated through interviews with leading Chinese medicine experts and a review of relevant clinical guidelines. Based on the results of a systematic review of authoritative textbooks and clinical research literature, a clinical question list, a clinical outcome assessment index for IMN, and a list of types of Chinese medicine syndromes were developed, and a national expert survey was conducted to identify the clinical questions included in this guideline. A systematic retrieval of evidence was conducted for the clinical questions included in the guideline, and its quality was assessed. Through an expert consensus meeting, 8 recommendations on the integrated traditional Chinese and Western medicine diagnosis and treatment for IMN were finalized. This guideline focuses on the clinical practice of integrated traditional Chinese and Western medicine in the diagnosis and treatment of IMN, and is applicable to healthcare workers who provide Chinese and Western medicine services.

Key words: Glomerulonephritis, membranous, Idiopathic membranous nephropathy, Integrated traditional Chinese and Western medicine, Chinese medicine therapy, Evidence-based practice, Diagnosis and treatment guideline

中图分类号: